Bayer is nearing the end of the road for glyphosate, executives say

Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.

Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.

More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.

Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.

Related Stories
“We believe that it is just a matter of days or weeks... before we see New World screwworm in Texas.”
The three-point plan was announced during remarks at the annual meeting of the National Association of State Departments of Agriculture.
According to the most recent version of the Household Food Security Report for 2022-2023, food insecurity is on the rise in the U.S.
Cindy Kovar with AgriSafe joined us on Monday’s Market Day Report to talk about road safety and agriculture as we age.
Andy Lee, with GHX Golden Harvest, discusses the mission of the Golden Harvest Experience, which gives farmers a personalized plan for their farm, including predictive seed placement and in-person support.